Value Creation in the Pharmaceutical Industry

Released on by Alexander Schuhmacher
preview-18

  • Value Creation in the Pharmaceutical Industry Book Detail

  • Author : Alexander Schuhmacher
  • Release Date : 2016-04-11
  • Publisher : John Wiley & Sons
  • Genre : Science
  • Pages : 511
  • ISBN 13 : 3527339132
  • File Size : 33,33 MB
DOWNLOAD BOOK

Value Creation in the Pharmaceutical Industry by Alexander Schuhmacher PDF Summary

Book Description: This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.

Disclaimer: www.yourbookbest.com does not own Value Creation in the Pharmaceutical Industry books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Mergers and Productivity

Mergers and Productivity

File Size : 67,67 MB
Total View : 3665 Views
DOWNLOAD

Mergers and Productivity offers probing analyses of high-profile mergers in a variety of industries. Focusing on specific acquisitions, it illustrates the remar